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We introduce a MeSH-based method that accurately quantifies similarity between 
heritable diseases at molecular level. This method effectively brings together the existing 
information about diseases that is scattered across the vast corpus of biomedical 
literature. We prove that sets of MeSH terms provide a highly descriptive representation 
of heritable disease and that the structure of MeSH provides a natural way of combining 
individual MeSH vocabularies. We show that our measure can be used effectively in the 
prediction of candidate disease genes. We developed a web application to query more 
than 28.5 million relationships between 7,574 hereditary diseases (96% of OMIM) based 
on our similarity measure. 
Over recent decades advances in proteomics have resulted in considerable gains in our 
understanding of heritable diseases and our perspective has evolved from simple gene-disease 
associations to considering diseases as perturbations in regions of the interactome – the disease 
modules1. In this context, related diseases are associated with close-by regions2,3. Quantifying 
disease similarity at molecular level would allow the transfer of knowledge between similar 
diseases4, possibly providing hypotheses for causal genes discovery and even suggestions for drug 
repositioning. 
Few methods for quantifying disease similarity at molecular level have recently appeared (see 
Supplementary material § 6). The method proposed by Park et al.5 calculates similarity between 
diseases as an association score between the different disease proteins based on their subcellular 
co-localisation. van Driel et al.4 present a measure based on text-mining analysis of the disease 
phenotype descriptions found in the OMIM compendium of heritable diseases6. These descriptions 
are mined for a predefined set of Medical Subject Headings (MeSH) terms which are used to 
construct feature vectors for every disease. Similarity between diseases is then given by the cosine 
of the angle between their respective feature vectors. Zhou et al.7 extract diseases and symptoms 
from MeSH, and through the mining of PubMed metadata they construct feature vectors describing 
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each disease in terms of its symptoms. Similarly to van Driel et al., the similarity between two 
diseases is given by the cosine of the angle between their respective feature vectors, followed by a 
filtering of similarities based on statistical significance. Robinson et al.8 explore a different approach 
by manually constructing the Human Phenotype Ontology (HPO). This ontology provides a 
standardised vocabulary for phenotypic information which is used to annotate OMIM diseases. 
Similarity between diseases is calculated using an information content-based similarity measure on 
the HPO. 
Results 
The approach we present here attempts to summarize existing information about diseases through 
large scale analysis of hand curated data. Our method is based on the idea that, for a given disease 
in OMIM, the set of MeSH terms annotating the publications referenced by its OMIM entry 
accurately describes that disease. This allows us to establish a mapping between diseases in OMIM 
and the MeSH ontology: every disease is annotated by the set of MeSH terms associated with its 
publications. Next, we use the structure of MeSH to measure the semantic similarity between the 
sets of terms annotating the diseases (see Methods).  Importantly, terms in MeSH are organised into 
16 ontologies according to thematic domains (e.g. Anatomy). Since a disease can be annotated by 
terms from several ontologies, this results in (up to) 16 similarity scores for each pair of diseases. 
Our in-depth analysis of MeSH revealed large overlaps between the ontologies (see Methods and 
Supplementary Discussion § 3 and 11) and we exploit this interconnectedness between the 
ontology structures in order to produce a single score which effectively encapsulates the diverse 
information available from the literature. In the following we show that our measure accurately 
reflects associations between underlying genes and proteins, hence characterising the relatedness 
between diseases at molecular level.  
To evaluate our measure and compare it to previous ones, we follow the approach used by van Driel 
et al.4 who proposed to quantify the molecular level similarity between diseases using three 
relationships between their disease proteins, namely physical interactions, domain co-occurrence 
based on Pfam9 and sequence similarity (see Methods and Supplementary material § 8). Thus, the 
evaluation is reduced to a binary classification problem, where disease similarity scores are used to 
predict these binary relationships. The performance of the measure is evaluated by computing the 
area under the ROC curve (AUC). Finally, another important criterion for a disease similarity method 
to be of practical importance is its wide applicability. Therefore, in our evaluation we included 
coverage, defined as the percentage of OMIM diseases for which similarities can be computed (see 
Supplementary Material § 4). Figure 1 Top presents a comparison between our method and a 
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representative set of other approaches namely Park5, van Driel4 and Robinson8. Both larger AUC 
values and larger coverage are better, and since these scores are all bound between 0 and 1, we sum 
them into a composite score to compare the methods’ overall performance.  The figure shows that 
our method outperforms earlier approaches. We also separately evaluated the performance of our 
measure on multigenic and monogenic diseases and we found it to be comparable (see 
Supplementary Material § 19, 23). 
To further assess the correlation of our similarity measure with the molecular level similarity, we 
contrast the distribution of similarity scores for all pairs of diseases with that of the subset of pairs 
sharing disease genes. This comparison is shown in Figure 1 Bottom as normalised histograms. The 
two distributions are very different (Student’s t-test P < 10-350). 90% of the pairs of diseases with 
shared genes have high-similarity scores (99th percentile or higher), indicating that high-similarity 
values are correlated with existing knowledge of relatedness at molecular level (see Supplementary 
Material § 7, 12, 14, 21).  
For many disease pairs with high similarity scores, we could readily verify that they are indeed 
similar at molecular level by analysing existing medical literature. For example, the score between 
Budd-Chiari (MIM: 600880) syndrome and Myeloproliferative disorder (MIM: 131440) is in the 97th 
percentile and genes associated to these diseases have in vivo verified first-level interactions (JAK2 – 
PDGFRB). Furthermore, it is known that these two diseases are causally related10. The score between 
Breast Cancer (MIM: 114480) and Noninsulin Dependent Diabetes (NDDIM) (MIM: 125853) lies in 
the 100th percentile, and several cancer related proteins are known to interact with NDDIM related 
proteins (TP53 – HNF4A, CDH1 – PTPN14, CDH1 – IRS1). Moreover, there exists statistical evidence 
of increased risk of Breast Cancer in Women with type 2 diabetes11. The similarity scores between 
Type I von Willebrand disease (VWD1) (MIM: 193400) and pseudo von Willebrand disease (VWDP) 
(MIM: 177820), two bleeding disorders, lies in the 100th percentile. VWD1 is a consequence of 
exceptionally low levels of plasma von Willebrand Factor (VWF)12 ,while VWDP is characterised by 
subtle mutations in the alpha subunit of the glycoprotein Ib (GPIbα) subunit, causing it to bond 
uncharacteristically to VWF13. 
One of the possible applications of our method lies in the transferring of knowledge between 
diseases and particularly in the prediction of candidate disease genes. To assess its effectiveness for 
this task, we built “old” similarity scores using an older version of OMIM (downloaded on April 9th, 
2013) and found that several pairs of diseases which had high similarity values according to data 
from 2013, have since been shown to be close on the interactome. For example, our 2013 version of 
OMIM reports no disease genes for SHORT syndrome (MIM: 269880), Dermatofibrosarcoma 
protuberans (MIM: 607907) and Right Atrial Isomerism (MIM: 208530). However, our “old” similarity 
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scores indicate SHORT syndrome to be very similar at molecular level to Noninsulin-dependent 
Diabetes Mellitus (MIM: 125853) (99th percentile), thus suggesting that disease genes for SHORT 
syndrome could be located in the neighbourhood of Diabetes. This is indeed the case, as the new 
version of OMIM links SHORT syndrome to gene PIK3R1, which has a verified in-vitro interaction 
with IRS1, a gene associated to noninsulin-dependent diabetes. Similarly, our “old” similarity scores 
indicate Dermatofibrosarcoma to be very similar at molecular level to Juvenile Myelomonocytic 
Leukemia (MIM: 607785) (100th percentile). The current version of OMIM shows an association 
between Leukemia and the gene PDGFRB, which interacts with PDGFB a gene associated to 
Dermatofibrosarcoma; the “old” score between Right Atrial Isomerism  and Tetralogy of Fallot  
(MIM: 187500) is in the 100th percentile and now it has been shown that they share a disease gene 
(GDF1). The list of publications available in the 2013 version of OMIM for each of the above diseases 
can be found in the Supplementary Discussion § 18. 
By exploring simpler measures based on the overlap between sets of MeSH terms, we prove that 
exploiting the structure of the MeSH ontology is essential to accurately quantify similarity between 
diseases at molecular level (see Supplementary  Discussion § 9). Finally, we show that the high 
accuracy of our similarity measure is due to both the quality of the MeSH terms which our approach 
assigns to OMIM diseases, as well as to the way in which our method uses the ontology structure 
(see Supplementary Discussion § 9, 15 and 16).  
Our measure allows us to obtain a 3D graphical representation of human diseases3 automatically. 
Figure 2 Top shows the embedding of diseases into 3D space obtained applying t-SNE14, a recently 
developed dimensionality reduction technique. In the figure, each point corresponds to a disease 
and the distance between two diseases relates to our similarity measure. Each disease is coloured 
according to the disease classes of Goh et al.3 who categorise each disease in OMIM into 19 classes 
according to the physiological system it affects.  The categories are:  Bone,  Cancer,  Cardiovascular,  
Connective tissue disorder, Dermatological,  Developmental, Ear-Nose-Throat, Endocrine,  
Gastrointestinal,  Haematological, Immunological,  Metabolic,  Multiple,  Muscular, Neurological, 
Nutritional, Ophthalmological, Psychiatric, Renal, Respiratory and  Skeletal. In the figure we show 
the diseases in the 10 most numerous classes (see Supplementary Discussion § 17). This plot reveals 
that diseases in the same class tend to be grouped together. This is interesting, as Goh et al. showed 
that these classes group diseases that are highly related at molecular level (see Supplementary 
Discussion § 17). 
Notice how some diseases which, from a phenotypical perspective belong to multiple classes, are 
placed appropriately at the boundaries between them (see diseases pointed by arrows in Figure 2 
Top). For example the Ring dermoid of Cornea (MIM: 180550), is located at the boundary between 
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the Dermatological, Cancer and Ophthalmological classes. This disease is characterised by dermoids 
(growths with a skin-like structure) in the eye; dermoids, in general, exhibit known hallmarks of 
cancer15. Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome 
(MIM: 609528) is characterised by severe neurological impairment as well as keratoderma and late-
onset ichthyosis16. Our embedding places this disease at the boundary between the Neurological and 
Dermatological classes. In other cases, diseases that belong to more than one class are placed closer 
to a class different from the one chosen by Goh et al.3, but their position is overall appropriate when 
considering the diseases’ characteristics. For example, lymphoproliferative syndrome, X-linked, 1 
(MIM: 308240), exhibits both immunological and cancer features. It is characterised by severe 
immunological dysregulation, and is related to several phenotypes (including lymphoma) and often 
occurs after an infection (Epstein-Barr virus). Our embedding places this disease closer to 
immunological diseases than to the cancer group. We discuss boundary diseases in more detail in 
Supplementary Discussion § 20. 
The clear grouping of diseases is made possible by the difference between average inter- and intra-
class similarity values – these are visualised as a heat map in Figure 2 Bottom. We also note that 
pairs of classes with high average inter-class similarity contain diseases which are often related. For 
example, this can be the case for diseases in the immune and respiratory classes as it is known that 
an abnormal immune response can cause chronic respiratory diseases17. 
We provide a full interactive browser at http://www.paccanarolab.org/disimweb which enables the 
user to obtain the similarity measure between over 28.5 million pairs of diseases. Connections to 
OMIM, MeSH and UniProtKB databases are also provided. The data and source code used to 
generate the similarity scores as well as the website is available for download from the same 
website. 
We have also developed the Disease Similarity Resource (DSR), a database of disease pairs whose 
similarity is in the top 5%. Each pair of diseases defines an entry with 5 columns: Disease A, Disease 
B, Similarity score, UniProt/KB identifiers of the proteins associated to disease A followed by those 
associated to disease B. These 1,552,356 pairs of highly similar diseases are a starting point for the 
analysis of the relationships between diseases as well as for the discovery of new disease genes (see 
Supplementary Material §22). The DSR is available from http://www.paccanarolab.org/disimweb in 
the “Download” section. 
Discussion 
In this paper we have introduced a method to obtain a high-quality score that characterise disease 
similarity at molecular level. We have shown that our method can be used to predict diseases whose 
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modules are located close on the interactome, allowing the transfer of knowledge between them. 
We can envision an interactive differential diagnosis system that would aid medical practitioners in 
identifying putative alternative diagnoses that are obscured by the complexity and multiplicity of the 
symptoms. 
Our method annotates diseases using the MeSH terms associated to the publications found in OMIM 
and then combines these annotations with the structure of the MeSH ontology. One important 
question is whether the method’s performance is due to the quality of the annotations, or to the 
way in which it exploits the structure of the MeSH ontology, or to both.  
In order to quantify the effects of MeSH’s ontological structure, we analysed the performance of 
similarity measures which disregard the ontology structure and are simply based on calculating the 
overlap of the MeSH terms annotating the diseases (See Methods). Therefore, these measures 
produce scores that do not depend on the specificity of the MeSH terms, equally weighing specific 
terms (e.g. Metatarsus - D008684) and broad ones (e.g. Body Regions - D001829).  Figure 4 presents 
a comparison between our method and these simple measures on the Pfam, PPI and Sequence 
Similarity datasets. While the coverage is the same as for our method, the performance of these 
simpler measures is inferior. When looking at the ROC curves in detail (see Supplementary figures  
3b, 3c, 3d) we understand that, as expected, these measures are conservative, being able to 
correctly produce high scores for very similar diseases, but being unable to provide appropriate 
lower scores for pairs of less similar diseases. It is important to note, however, that while the use of 
MeSH’s ontological structure improves performance significantly not all semantic similarity 
measures are well suited for the MeSH ontology. A comparison with the semantic similarity 
measures by Lin18, Jiang19, simUI20  and simGIC20 (see Methods)  shows that the measure by Resnik, 
used in our method, performs best (see Figure 5 and Supplementary Discussion § 10). The lower 
performance of Lin’s and Jiang’s methods is due to the fact that using these measures, if the sets of 
MeSH terms annotating two diseases overlap, their similarity will always be maximal, irrespective of 
the specificity of the terms in the annotations. This is not a problem when calculating semantic 
similarities between genes using the Gene Ontology, as gene GO annotations in general overlap little 
compared to disease Mesh annotations—see Supplementary Figure 5 which compares the overlap 
of MeSH terms for OMIM diseases with the overlap of GO terms for genes in A. thaliana, H. sapiens, 
M. musculus, S. cerevisiae and C. elegans. Therefore, Lin’s and Jiang’s measures produce an 
incorrectly large proportion of high-similarity pairs. Conversely, simUI and simGIC, although they 
exploit the structure of the ontology to expand the set of terms, are ultimately based on the overlap 
of MeSH terms and therefore behave similarly to the aforementioned simpler measures. 
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In order to quantify the effects of the quality of our disease annotations, we replaced them with the 
OMIM-to-MeSH mapping used by van Driel’s et al. This was possible due to the fact that van Driel 
also uses sets of MeSH terms to annotate the diseases. However, these annotations were obtained 
text-mining the Clinical Synopsis and Text fields of OMIM for terms in the A (Anatomy) and C 
(Diseases) ontologies in MeSH. Supplementary Figures 29, 30 and 31 show the evaluation results for 
the Pfam, PPI and Sequence Similarity datasets highlighting the fact that the sets of MeSH terms 
associated with the publications for a given disease are informative descriptors for that disease. 
Our analysis shows that the MeSH terms associated to the publications referenced in OMIM are 
good descriptors of the diseases themselves, and that the MeSH ontology structure provides 
valuable information for calculating distances between sets of terms. Combining these two, we 
obtain a high-quality score that characterises disease similarity at molecular level. 
 
Methods 
OMIM entries describe individual diseases and are composed of several plain text fields as well as 
references to scientific publications provided in the form of PubMed identifiers.  These identifiers 
provide access to the MEDLINE entry for the linked reference from which metadata can be retrieved, 
including the MeSH terms. From the 21st of July 2014 version of OMIM we obtained 7,574 disease 
phenotypes referencing 62,830 publications. These publications were associated with 13,220 MeSH 
Main Heading terms which we used to annotate the OMIM diseases. The “old” OMIM dataset, used 
to showcase the potential of our method to predict disease genes, corresponds to the release of 
April 9th 2013 of OMIM. This version contains 7,525 diseases referencing 61,889 publications 
annotated with 13,006 MeSH Main Heading terms. For details, please refer to Supplementary 
material § 2 and 11.   
Experimental results presented here use the similarity measure proposed by Resnik21. Resnik’s 
semantic similarity between two terms in an ontology is based on the concept of information 
content of a term, defined as the negative logarithm of the probability of that term (calculated as 
the ratio between the number of diseases annotated by that term and the total number of 
annotated diseases). The similarity of two terms 𝑐1, 𝑐2 is defined as the information content of their 
common ancestor with highest information content, that is: 
𝑠𝑖𝑚(𝑐1, 𝑐2) =  max
𝑐 ∈𝑆(𝑐1,𝑐2)
− log 𝑝(𝑐)            (1) 
where 𝑆(𝑐1, 𝑐2) is the set of common ancestors of  𝑐1, 𝑐2 and − log 𝑝(𝑐) is the information content 
of term 𝑐. We defined the similarity of two diseases 𝑑1, 𝑑2 as the maximum similarity for all possible 
pairs of MeSH terms 𝑐1, 𝑐2 annotating the disease pair, that is: 
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𝑠𝑖𝑚(𝑑1, 𝑑2) = max
𝑐1∈𝑑1,   𝑐2∈𝑑2
[𝑠𝑖𝑚(𝑐1, 𝑐2)]      (2) 
Thus, for every pair of diseases in OMIM, we obtain a different similarity score for each MeSH 
ontology in which both diseases are annotated. Our analysis of the interconnectedness of the MeSH 
ontologies allowed us to combine them, thus obtaining a single similarity score for each pair of 
diseases. The basis for the combination lies in the fact that some terms are shared between MeSH 
ontologies, and this overlap creates a series of paths which link them together into a single 
ontological structure. Figure 3 shows the pairwise overlap between the different ontologies 
quantified by their Jaccard coefficient. Results presented here are obtained using the ontologies 
which had an AUC above 60% for the PPI dataset while maintaining a high coverage of OMIM 
diseases, namely Anatomy [A] (6,781 diseases), Diseases [C] (7,321 diseases), Chemicals and Drugs 
[D] (7,575 diseases), Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] (7,000 
diseases) and Phenomena and Processes [G] (7,018 diseases).  We also tried other combinations and 
we found results to be equivalent as long as we included ontologies with high coverage. 
Performance and coverage of the proposed method in each individual ontology is shown in the 
Supplementary Discussion (§ 12, 13 and 14). As for most measures of semantic similarity between 
genes, our disease similarity measure is an unbounded, non-negative real number. We chose not to 
apply any order preserving transformation in order to rescale the scores, as it would have no effect 
on performance and could make it dataset-dependent or lead to misinterpretations (e.g. values 
constrained between zero and one might be wrongly interpreted as probabilities). 
For the evaluation of our disease similarity measure and its comparison with existing measures, we 
follow the approach presented by van Driel et al.4, and assess the accuracy of our scores with 
respect to three binary relationships defining molecular relatedness between the 4,030 diseases 
with known proteins. The different measures are evaluated by comparing their performance on a 
classification problem, where the disease similarity scores are used to predict molecular level 
similarity, as represented by the three relationships. The relative performance of the different 
measures can then be compared using the Area under the ROC curve (AUC)22. We acknowledge that 
this evaluation is far from perfect due to limitations in the available molecular information of the 
diseases. 
The first relationship proposed by van Driel et al. determines molecular relatedness based on 
protein-protein interactions between disease proteins. Two diseases are related if any of their 
disease proteins interact according to the Human Protein Reference Database (HPRD). This 
relationship resulted in 15,515 disease pairs relating 2,512 OMIM diseases. The second relationship 
is based on the co-occurrence of Pfam-A signatures (i.e. families, domains, motifs or repeats), and it 
relates two diseases if any of their disease-proteins share at least one of these signatures. After 
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excluding disease pairs in which Pfam-A signatures  associated to proteins in the pair matched a 
MeSH term as well as disease pairs with identical proteins, this relationship results in 33,660 pairs 
relating 2,647 OMIM diseases. The last relationship proposed by van Driel et al. is based on 
sequence similarity, and it relates two diseases whenever any of their disease proteins are similar in 
sequence. Sequence similarity is determined with a Smith-Waterman local alignment of the 
sequences with a threshold e-value smaller or equal to 10^-6. After excluding disease pairs with 
identical proteins this criterion results in 37,486 diseases pairs relating 2,817 OMIM diseases. 
Further details on the construction of these test datasets can be found in the Supplementary 
Discussion § 8.  
The visualisation presented in Figure 2 Top results from a 3d embedding of the diseases using t-
SNE14 using the default parameters (perplexity set to 30 and number of dimensions for PCA pre-
processing set to 50). The figure shows the diseases in the 10 most populated classes of Goh et al. 
(661 diseases in total).  
We compared the performance of our measure with that of four simpler similarity measures 
(Jaccard, Dice, Overlap, Num. Common) which are based on calculating the overlap of the MeSH 
terms annotating the diseases and do not exploit the MeSH ontological structure. Given two 
diseases, a and b, their similarity sim(a,b), is defined as follows: 
1. Jaccard: uses the Jaccard coefficient of their respective annotation sets. Formally:   
sim(a,b) =
|Annot(a) ∩ Annot(b) |
|Annot(a) ∪ Annot(b) |
                       (3) 
2. Dice: uses the Sørensen–Dice coefficient of their respective annotation sets. Formally:  
sim(a,b) =
2 ∗ |Annot(a) ∩ Annot(b) |
|Annot(a)| +  |Annot(b)|
                (4) 
3. Overlap: 
𝑠𝑖𝑚(𝑎,𝑏) =
|𝐴𝑛𝑛𝑜𝑡(𝑎) ∩ 𝐴𝑛𝑛𝑜𝑡(𝑏) |
min (|𝐴𝑛𝑛𝑜𝑡(𝑎)|, |𝐴𝑛𝑛𝑜𝑡(𝑏)|)
           (5) 
4. Num. Common: the size of the intersection of their annotation sets. Formally: 
 𝑠𝑖𝑚(𝑎,𝑏) = |𝐴𝑛𝑛𝑜𝑡(𝑎) ∩ 𝐴𝑛𝑛𝑜𝑡(𝑏) |                      (6) 
We compared the performance of our method which uses the Resnik measure, with that of four 
alternative similarity measures (Lin, Jiang, simUI, simGIC), which also exploit the ontology structure, 
by considering all the terms in the path to the root (True Path Rule). 
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1. Lin18: uses the  normalised Resnik’s measure to account for the divergence between the 
terms: 
 sim(a,b) = max
c1∈a,   c2∈b
 (
2 ∗ ( max
c ∈S(c1,c2)
− log p(c))
log(p(a)) + log (p(b))
)                                       (7) 
             
2. Jiang19: uses a distance measure: 
D(a,b) = max
c1∈a,   c2∈b
 2 ∗ ( max
c ∈S(c1,c2)
− log p(c)) − log(p(a)) − log(p(b))       (8)  
This distance measure is then transformed into a similarity score: 
    sim(a,b) =  1 −
D(a,b)
M
                                                                                              (9)  
where M is the maximum possible value of 𝐷(𝑎,𝑏). 
3. simUI20:  
sim(a,b)  
|terms(a) ∩ terms(b)|
|terms(a) ∪ terms(b)| 
                                                                          (10) 
4. simGIC20: improves on simUI and it is based on a weighted Jaccard index, where the weight 
of each element is its information content 22. Similarity between two diseases a ,b is defined 
as: 
 sim(a,b) =  
∑ IC(t)t ∈ terms(a)∩terms(b)
∑ IC(t)t ∈ terms(a)∪terms(b)
                                                                  (11) 
Additional details of these alternative similarity measures can be found in the supplementary 
material (see Supplementary Discussion § 5). 
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Figure 1. Top) Performance Comparison. For each method, the grey bar quantifies its OMIM coverage, coloured bars 
quantify its performance measured by AUCs on the Pfam, PPI and Sequence Similarity datasets. The total length of each bar 
represents the overall performance of each method. Bottom) Comparison of score distributions.  Distribution of similarity 
scores for all pairs of diseases (yellow bars) vs.  distribution of similarity scores for disease pairs sharing one or more disease 
genes (green bars). 90% of the pairs of diseases with shared genes have scores in the 99th percentile or higher. 
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Figure 2. Top) Embedding of hereditary diseases in 3D space using t-SNE. Each point represents an OMIM disease. Colours 
are assigned based on their disorder class according to Goh et al.3. Highlighted diseases belong to multiple phenotypic 
classes and are discussed in the main text. Bottom) Heat map of mean class similarities. Each (x,y) tile represents, for the 
disease classes in Goh et al.3, the mean similarity of disease pairs where one disease belongs to class x and the other to 
class y. The values range from 1.15 (Gastrointestinal – Ear, nose, throat) to 2.71 (Nutritional-Nutritional). The colours range 
between the minimum mean similarity and 2, with all values above 2 (In the diagonal: 2.01 Bone, 2.05 Immunological, 2.06 
Gastrointestinal, 2.07 Muscular, 2.1 Psychiatric, 2.2 Cancer, 2.5 Respiratory, 2.71 Nutritional) set to 2.   Inset: the average 
intra-class similarity is significantly higher than the average inter-class similarity (t-test p-value < 10^-350).  
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igure 3. Overlap of the MeSH ontologies. Nodes represent MeSH ontologies and links are related to the amount of overlap 
between them. Link colours correspond to the Jaccard coefficient between the set of terms in each pair of ontologies. Link 
thicknesses correspond to the number of shared terms between ontologies and only strictly positive links are shown. MeSH 
Ontologies abbreviations: [A] Anatomy, [B] Organisms, [C]Diseases, [D] Chemicals and drugs, [E]  Analytical, Diagnostic and 
Therapeutic Techniques and Equipment, [F] Psychiatry and Psychology, [G] Phenomena and Processes, [H] Disciplines and 
Occupations, [I] Anthropology, Education, Sociology and Social Phenomena, [J] Technology, Industry, Agriculture,  [K] 
Humanities, [L], Information Science,  [M] Named Groups, [N] Health Care, [V] Publication Characteristics, [Z] Geographical. 
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Figure 4 Effects of MeSH’s ontological structure. The performance of our method, which uses the MeSH ontology structure, 
is better than the simpler, overlap based methods. For each method, the grey bar quantifies its OMIM coverage, coloured 
bars quantify its performance measured by AUCs on the Pfam, PPI and Sequence Similarity datasets. The total length of 
each bar represents the overall performance of the method. 
 
Figure 5 Correct use of the ontology structure. The improved performance of Resnik’s measure, used by our method, is due 
to a better use of the ontological structure. For each method, the grey bar quantifies its OMIM coverage, coloured bars 
quantify its performance measured by AUCs on the Pfam, PPI and Sequence Similarity datasets. The total length of each bar 
represents the overall performance of the method. 
 
